ClinicalTrials.Veeva

Menu

Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)

S

Sykehuset Telemark

Status

Completed

Conditions

Reproductive Techniques, Assisted

Treatments

Drug: Acetyl Salicylic Acid and Terbutalin

Study type

Interventional

Funder types

Other

Identifiers

NCT00518141
S-06085 (REK)

Details and patient eligibility

About

This study aims to determine the possible effects of Acetyl Salicylic Acid (ASA) and Terbutalin on ART treatment.

Full description

This study aims to determine the possible effects of ASA and Terbutalin on ART treatment.

Enrollment

300 patients

Sex

Female

Ages

18 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infertile women below 39 years of age

Exclusion criteria

  • Women who may react allergically to the drugs administered
  • Women with hyperthyroid or IDDM
  • Women who do not want to participate in the study
  • Women who are unable to give informed, written consent.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

300 participants in 6 patient groups

1
Experimental group
Description:
FER
Treatment:
Drug: Acetyl Salicylic Acid and Terbutalin
2
No Intervention group
Description:
FER
3
Experimental group
Description:
SET
Treatment:
Drug: Acetyl Salicylic Acid and Terbutalin
4
No Intervention group
Description:
SET
5
Experimental group
Description:
DET
Treatment:
Drug: Acetyl Salicylic Acid and Terbutalin
6
No Intervention group
Description:
DET

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems